Aripiprazole, sold under the brand names Abilify and Aristada, among others, is an atypical antipsychotic. It is primarily used in the treatment of schizophrenia...
105 KB (9,658 words) - 13:54, 30 September 2024
Aripiprazole/sertraline (developmental code name ASC-01) is a combination formulation of aripiprazole (Abilify), an atypical antipsychotic, and sertraline...
3 KB (157 words) - 02:21, 5 November 2023
Aripiprazole lauroxil, sold under the brand name Aristada, is a long-acting injectable atypical antipsychotic that was developed by Alkermes. It is an...
17 KB (1,741 words) - 13:26, 28 August 2024
developed by Otsuka and Lundbeck, and is considered to be a successor to aripiprazole (Abilify). It was approved for medical use in the United States in July...
31 KB (2,342 words) - 05:42, 13 September 2024
The rates of adverse effects of aripiprazole are: Weight gain Headache Agitation Insomnia Anxiety Nausea & vomiting Akathisia — a sense of unease and restlessness...
9 KB (723 words) - 14:13, 12 April 2024
effects complicate the choice. In turn, risperidone, olanzapine, and aripiprazole have been recommended for the treatment of first-episode psychosis. The...
100 KB (9,275 words) - 03:29, 9 October 2024
antipsychotic to an (or to a different) atypical antipsychotic, such as aripiprazole, ziprasidone, quetiapine, olanzapine, risperidone, or clozapine. These...
13 KB (1,359 words) - 06:00, 24 March 2024
hyperactive muscle fibres thus reducing involuntary movement production. Aripiprazole is an FDA-approved antipsychotic drug that "acts as an antagonist at...
23 KB (2,740 words) - 03:39, 22 September 2024
of schizophrenia, including avolition. According to a 2015 article, aripiprazole may be useful for treatment of apathy syndrome (avolition). However,...
10 KB (1,095 words) - 16:49, 12 October 2024
Pipotiazine undecylenate Zuclopenthixol acetate Zuclopenthixol decanoate Aripiprazole lauroxil Paliperidone palmitate ATC code N05A DrugBank WHO ATC codes...
8 KB (49 words) - 20:57, 11 August 2023